# US 2024/0246905 A1 · Vinyl isocyanide compounds as antibacterial agents

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0246905 A1
- Document ID: US20240246905A1
- Status: Published application
- Kind: A1
- Application number: 18/290,241
- Filed: 2022-05-10
- Published: 2024-07-25
- Earliest claimed: 2021-05-13
- Assignees: University of Leicester
- Applicants: University of Leicester
- Inventors: Steven D. Bull; Liam J. Stephens
- Web page: https://patentgrep.com/patent/US20240246905A1

## CPC

- C07C 291/10: Isocyanides
- A61K 31/277: having a ring, e.g. verapamil
- A61K 31/4409: only substituted in position 4, e.g. isoniazid, iproniazid
- A61K 31/505: Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61P 31/04: Antibacterial agents
- C07D 213/36: Radicals substituted by singly-bound nitrogen atoms (nitro radicals C07D213/26)
- C07D 213/57: Nitriles
- C07D 239/26: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07C 2601/16: the ring being unsaturated
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Compounds of formula (I) or formula (II) are disclosed: Wherein Y1, Y2 and Y3 are independently selected from C—R1 or N. Such compounds find use as antibiotics and antifungals.

## Claims

### Claim 1

A compound of formula (I) or formula (II):
or a salt, solvate, diastereomer or tautomer thereof, wherein:
Y1, Y2 and Y3 are independently selected from C—R1 or N;
each R1 is independently selected from H, C1 to C6 alkyl, OH, OR, NHCOR, NHSO2R, CONHR, CONHSO2R, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl or R7; and each R is independently selected from H, or C1 to C6 alkyl;
R2 is selected from substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or R7;
R3 and R4 are independently selected from H, or C1 to C6 alkyl;
R7 is a group of formula:
Ra and Rb are independently selected from H, or C1 to C6 alkyl; or Ra and Rb together with the atoms to which they are attached, form a substituted or unsubstituted 5 or 6 membered ring;
R5 is selected from substituted or unsubstituted aryl or heteroaryl; and
R6 is selected from H, or C1 to C6 alkyl.

### Claim 2 (depends on 1)

A compound as claimed in claim 1, wherein the substituted or unsubstituted 5 or 6 membered ring comprises a substituted or unsubstituted cyclyl or heterocyclyl ring, suitably a C5-20 cyclyl or C5-10 heterocyclyl.

### Claim 3 (depends on 1, 2)

A compound as claimed in claim 1 or claim 2, wherein the substituted or unsubstituted 5 or 6 membered ring comprises a substituted or unsubstituted aryl or heteroaryl ring or a ring forming one ring of a fused ring structure, suitably wherein the substituted or unsubstituted 5 or 6 membered ring comprises a substituted or unsubstituted C5-20 aryl or C5-10 heteroaryl.

### Claim 4

A compound as claimed in any one of the preceding claims, wherein the substituted or unsubstituted 5 or 6 membered ring is selected from pyrrolidine, pyrrole, pyridine, furan, thiophene, oxazole, isoxazole, isoxazine, oxadiazole (e.g. 1-oxa-2,3-diazolyl, 1-oxa-2,4-diazolyl, 1-oxa-2,5-diazolyl, 1-oxa-3,4-diazolyl), oxatriazole, thiazole, isothiazole, imidazole, pyrazole, pyridazine, pyrimidine, pyrazine, triazole (e.g. 1,2,4-triazole), triazine (e.g. 1,2,4-triazine), tetrazole, azaindole (e.g. 5-azaindole or 7-azaindole), azaindazole (e.g. 7-azaindolazole), azabenzimidazole (e.g. 5-azabenzimidazole), benzofuran, isobenzofuran, indole, quinoline, quinazoline, isoindole, indolizine, isoindoline, benzothiofuran, benzoxazole, benzisoxazole, benzothiazole, benzimidazole, indazole, benzodioxole, benzofurazan, benzothiadiazole, benzotriazole, purine (e.g., adenine, guanine), pyrrolo[1,2-a]pyrazine, pyrazolo[1,5-a]pyridine, 1H-pyrazolo[3,4-d]pyrimidine, pyrazolo[1,5-b]pyridazine, and pteridine.

### Claim 5

A compound as claimed in any one of the preceding claims, wherein the compound is of formula (III):
wherein R1 is selected from H, C1 to C6 alkyl, OH, OR, NHCOR, NHSO2R, CONHR, CONHSO2R or substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl;
Y1, Y2 and Y3 are independently selected from C—R1 or N; and
each R is independently selected from H, or C1 to C6 alkyl.

### Claim 6

A compound as claimed in any one of the preceding claims, wherein the compound is of formula (IV):
wherein R6 and R7 are independently selected from H, C1 to C6 alkyl, OH, or OR; or R6 and R7 together with the atoms to which they are attached form a substituted or unsubstituted 6 membered ring.

### Claim 7 (depends on 6)

A compound as claimed in claim 6, wherein the compound is of formula (V):
wherein the dotted lines to X and Y each independently indicate the optional presence of a bond; and X and Y are each independently selected from C(R)n or N(R)m; wherein n is 1 or 2 and m is 0 or 1 depending on the optional presence of a bond; with the proviso that at least one of the dotted lines to X and Y indicate the presence of a bond.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6)

A compound as claimed in any one of claim 1 to 6, wherein the compound is of formula (V):

### Claim 9

A compound as claimed in any one of the preceding claims, wherein R5 is substituted or unsubstituted aryl, pyridyl, pyrazyl, pyridazyl or pyrimidyl.

### Claim 10

A compound as claimed in any one of the preceding claims, wherein R3 and R4 are each H.

### Claim 11

A compound as claimed in any one of the preceding claims, wherein each of Y1, Y2 and Y3 are each C—R1.

### Claim 12

A compound as claimed in any one of the preceding claims, wherein at least one R1 is selected from OH, OR, NHCOR, NHSO2R, CONHR, CONHSO2R, wherein each R is independently selected from H, or C1 to C6 alkyl.

### Claim 13

A compound as claimed in any one of the preceding claims, wherein the compound is selected from compounds of formulae:

### Claim 14 (depends on 1)

A method of producing a vinyl isocyanide compound of claim 1, the method comprising:
a) providing a phosphonate of formula (X):
wherein R11 and R12 are independently selected from C3 to C5 alkyl, optionally independently selected from isopropyl, isobutyl, and t-butyl.
b) reacting the phosphonate with a carbonyl compound in the presence of base.

### Claim 15 (depends on 14)

A method as claimed in claim 14, wherein the carbonyl compound is a compound of formula (XI) or (XII):
wherein, Y1, Y2 and Y3 are independently selected from C—R1 or N;
each R1 is independently selected from H, C1 to C6 alkyl, OH, OR, NHCOR, NHSO2R, CONHR, CONHSO2R, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl or R7; and each R is independently selected from H, or C1 to C6 alkyl;
R2 is selected from substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or R7;
R3 is selected from H, or C1 to C6 alkyl;
R7 is a group of formula:
Ra and Rb are independently selected from H, or C1 to C6 alkyl; or Ra and Rb together with the atoms to which they are attached, form a substituted or unsubstituted 5 or 6 membered ring;
R5 is selected from substituted or unsubstituted aryl or heteroaryl; and
R6 is selected from H, or C1 to C6 alkyl.

### Claim 16 (depends on 14, 15)

A method as claimed in either claim 14 or claim 15, wherein the base comprises a non-nucleophilic base, optionally a Li base, optionally a base selected from lithium bis(trimethylsilyl)amide (LHMDS), lithium tetramethylpiperidide (LiTMP), and lithium diisopropylamide (LDA).

### Claim 17 (depends on 14, 15, 16)

A method as claimed in any one of claims 14 to 16 wherein R3 is H.

### Claim 18 (depends on 14, 15, 16, 17)

A method as claimed in any one of claims 14 to 17, wherein the phosphonate is reacted with a carbonyl in the presence of base and THE as solvent.

### Claim 19 (depends on 14)

A reagent for use in the method of claim 14, the reagent comprising a compound of formula (X):
wherein R11 and R12 are independently selected from C3 to C5 alkyl, optionally independently selected from isopropyl, isobutyl, and t-butyl.

### Claim 20 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

A compound of formula (I) or (II) and salts and solvates thereof according to any one of claims 1 to 13 for use as a medicament.

### Claim 21 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

A compound of formula (I) or (II) and salts and solvates thereof according to any one of claims 1 to 13 for use in the treatment of an infectious disease.

### Claim 22 (depends on 21)

A compound of formula (I) or (II) and salts and solvates thereof according to claim 21 for use in the treatment of a bacterial, fungal or protozoal disease.

### Claim 23 (depends on 22)

A compound of formula (I) or (II) and salts and solvates thereof according to claim 22, wherein the bacterial disease is a disease caused by gram negative bacteria, or gram positive bacteria.

### Claim 24 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

A pharmaceutical composition comprising a compound of formula (I) or (II) and salts and solvates thereof of any one of claims 1 to 13 and a pharmaceutically acceptable excipient, carrier or diluent.

### Claim 25 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The use of a compound of formula (I) or (II) and salts and solvates thereof according to any one of claims 1 to 13 in the manufacture of a medicament, optionally for treating an infectious disease.

### Claim 26 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 17)

A method of treatment of a subject, comprising administering to said subject a therapeutically effective amount of a compound of any one of claims 1 to 13 or a pharmaceutical composition of claim 17, optionally wherein the subject is suffering from an infectious disease.
